The Diagnostic Utility of the Basal Luteinizing Hormone Level and Single 60-Minute Post GnRH Agonist Stimulation Test for Idiopathic Central Precocious Puberty in Girls
- PMID: 34456870
- PMCID: PMC8387794
- DOI: 10.3389/fendo.2021.713880
The Diagnostic Utility of the Basal Luteinizing Hormone Level and Single 60-Minute Post GnRH Agonist Stimulation Test for Idiopathic Central Precocious Puberty in Girls
Abstract
Objective: The present study aimed to assess the diagnostic utility of the Luteinizing hormone (LH) levels and single 60-minute post gonadotropin-releasing hormone (GnRH) agonist stimulation test for idiopathic central precocious puberty (CPP) in girls.
Methods: Data from 1,492 girls diagnosed with precocious puberty who underwent GnRH agonist stimulation testing between January 1, 2016, and October 8, 2020, were retrospectively reviewed. LH levels and LH/follicle-stimulating hormone (FSH) ratios were measured by immuno-chemiluminescence assay before and at several timepoints after GnRH analogue stimulation testing. Mann-Whitney U test, Spearman's correlation, χ2 test, and receiver operating characteristic (ROC) analyses were performed to determine the diagnostic utility of these hormone levels.
Results: The 1,492 subjects were split into two groups: an idiopathic CPP group (n = 518) and a non-CPP group (n = 974). Basal LH levels and LH/FSH ratios were significantly different between the two groups at 30, 60, 90, and 120 minutes after GnRH analogue stimulation testing. Spearman's correlation analysis showed the strongest correlation between peak LH and LH levels at 60 minutes after GnRH agonist stimulation (r = 0.986, P < 0.001). ROC curve analysis revealed that the 60-minute LH/FSH ratio yielded the highest consistency, with an area under the ROC curve (AUC) of 0.988 (95% confidence interval [CI], 0.982-0.993) and a cut-off point of 0.603 mIU/L (sensitivity 97.3%, specificity 93.0%). The cut-off points of basal LH and LH/FSH were 0.255 mIU/L (sensitivity 68.9%, specificity 86.0%) and 0.07 (sensitivity 73.2%, specificity 89.5%), respectively, with AUCs of 0.823 (95% CI, 0.799-0.847) and 0.843 (95% CI, 0.819-0.867), respectively.
Conclusions: A basal LH value greater than 0.535 mIU/L can be used to diagnose CPP without a GnRH agonist stimulation test. A single 60-minute post-stimulus gonadotropin result of LH and LH/FSH can be used instead of a GnRH agonist stimulation test, or samples can be taken only at 0, 30, and 60 minutes after a GnRH agonist stimulation test. This reduces the number of blood draws required compared with the traditional stimulation test, while still achieving a high level of diagnostic accuracy.
Keywords: GnRH agonist stimulation test; central precocious puberty; follicle-stimulating hormone; luteinizing hormone; pediatrics.
Copyright © 2021 Cao, Liu, Fu, Zhou, Li and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Diagnostic Value of Single LH and LH/FSH Ratio at 60-minute after GnRHa Stimulation Test for Central Precocious Puberty.Indian J Pediatr. 2025 Aug;92(8):853-859. doi: 10.1007/s12098-024-05137-7. Epub 2024 May 13. Indian J Pediatr. 2025. PMID: 38739362 Free PMC article.
-
The effect of obesity on the GnRH stimulation test in girls with idiopathic central precocious puberty.Eur J Pediatr. 2025 Mar 17;184(4):254. doi: 10.1007/s00431-025-06077-w. Eur J Pediatr. 2025. PMID: 40095159 Free PMC article.
-
Diagnostic Value of LH Peak Value of the GnRH Stimulation Test for Girls with Precocious Puberty and Its Correlation with Body Mass Index.Comput Math Methods Med. 2022 Jun 2;2022:4118911. doi: 10.1155/2022/4118911. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Dec 6;2023:9862939. doi: 10.1155/2023/9862939. PMID: 35693257 Free PMC article. Retracted.
-
Effect of CPP-related genes on GnRH secretion and Notch signaling pathway during puberty.Biomed J. 2023 Apr;46(2):100575. doi: 10.1016/j.bj.2022.12.003. Epub 2022 Dec 15. Biomed J. 2023. PMID: 36528337 Free PMC article. Review.
-
Comparison of central precocious puberty frequency before and during COVID-19: a systematic review and meta-analysis.BMC Endocr Disord. 2024 Oct 17;24(1):219. doi: 10.1186/s12902-024-01749-4. BMC Endocr Disord. 2024. PMID: 39420314 Free PMC article.
Cited by
-
The value of luteinizing hormone basal values and sex hormone-binding globulin for early diagnosis of rapidly progressive central precocious puberty.Front Endocrinol (Lausanne). 2024 Jan 22;14:1273170. doi: 10.3389/fendo.2023.1273170. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38317710 Free PMC article.
-
Diagnostic Value of Single LH and LH/FSH Ratio at 60-minute after GnRHa Stimulation Test for Central Precocious Puberty.Indian J Pediatr. 2025 Aug;92(8):853-859. doi: 10.1007/s12098-024-05137-7. Epub 2024 May 13. Indian J Pediatr. 2025. PMID: 38739362 Free PMC article.
-
Early warning value of multiple serum indicators combined with ultrasound detection in girls with central precocious puberty.Front Endocrinol (Lausanne). 2025 Apr 7;16:1518764. doi: 10.3389/fendo.2025.1518764. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40260284 Free PMC article.
-
Trends of Age at Onset of Menarche Among Indian Women of Reproductive Age and Its Association with the Presence of PCOS and Related Features: A Multicentric Cross Sectional Study.J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):70-77. doi: 10.1007/s13224-024-01994-6. Epub 2024 Jul 29. J Obstet Gynaecol India. 2025. PMID: 40390937
-
Differential diagnosis of precocious puberty in girls during the COVID-19 pandemic: a pilot study.BMC Pediatr. 2023 Apr 20;23(1):185. doi: 10.1186/s12887-023-04009-x. BMC Pediatr. 2023. PMID: 37081435 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources